Gene · 9260
Papers4,249
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 4,249
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Characteristics and Outcome of Extranodal NK/T-Cell Lymphoma in North America: A Retrospective Multi-Institutional Experience. | Clin Lymphoma Myeloma Leuk | 2022 | 34794912 | PubTator, text mining | PubMed |
| New insights into Epstein‑Barr virus‑associated tumors: Exosomes (Review). | Oncol Rep | 2022 | 34779497 | PubTator, text mining | PubMed |
| Persistent SARS-CoV-2 infection with repeated clinical recurrence in a patient with common variable immunodeficiency. | Clin Microbiol Infect | 2022 | 34774757 | PubTator, text mining | PubMed |
| Analysis of senescence-responsive stress fiber proteome reveals reorganization of stress fibers mediated by elongation factor eEF2 in HFF-1 cells. | Mol Biol Cell | 2022 | 34705524 | PubTator, text mining | PubMed |
| An investigation into DNA methylation patterns associated with risk preference in older individuals. | Epigenetics | 2022 | 34696705 | PubTator, text mining | PubMed |
| Viral Modulation of the DNA Damage Response and Innate Immunity: Two Sides of the Same Coin. | J Mol Biol | 2022 | 34695379 | PubTator, text mining | PubMed |
| CD4 + T cells are found within endemic Burkitt lymphoma and modulate Burkitt lymphoma precursor cell viability and expression of pathogenically relevant Epstein-Barr virus genes. | Cancer Immunol Immunother | 2022 | 34668039 | PubTator, text mining | PubMed |
| Exosomes: Emerging implementation of nanotechnology for detecting and managing novel corona virus- SARS-CoV-2. | Asian J Pharm Sci | 2022 | 34630723 | PubTator, text mining | PubMed |
| The role of CD4 T cells in rejection of solid tumors. | Curr Opin Immunol | 2022 | 34619457 | PubTator, text mining | PubMed |
| Continuous polymerase chain reaction microfluidics integrated with a gold-capped nanoslit sensing chip for Epstein-Barr virus detection. | Biosens Bioelectron | 2022 | 34601264 | PubTator, text mining | PubMed |
| Cancers associated with human gammaherpesviruses. | FEBS J | 2022 | 34536980 | PubTator, text mining | PubMed |
| Clinico-biological features and outcome of patients with splenic marginal zone lymphoma with histological transformation. | Br J Haematol | 2022 | 34519021 | PubTator, text mining | PubMed |
| Tumor-associated antigen-specific T cells with nivolumab are safe and persist in vivo in relapsed/refractory Hodgkin lymphoma. | Blood Adv | 2022 | 34495306 | PubTator, text mining | PubMed |
| Classical Hodgkin's lymphoma with cutaneous involvement in an adolescent male: A case study. | Cancer Rep (Hoboken) | 2022 | 34089301 | PubTator, text mining | PubMed |
| Impact of lean service, workplace environment, and social practices on the operational performance of India post service industry. | Ann Oper Res | 2022 | 33967367 | PubTator, text mining | PubMed |
| Burkitt lymphoma with a granulomatous reaction: an M1/Th1-polarised microenvironment is associated with controlled growth and spontaneous regression. | Histopathology | 2022 | 33948980 | PubTator, text mining | PubMed |
| Adaptive threshold-based alarm strategies for continuous vital signs monitoring. | J Clin Monit Comput | 2022 | 33575922 | PubTator, text mining | PubMed |
| Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies. | Explor Target Antitumor Ther | 2021 | 36046116 | PubTator, text mining | PubMed |
| DMRT2 Interacts With FXR and Improves Insulin Resistance in Adipocytes and a Mouse Model. | Front Endocrinol (Lausanne) | 2021 | 35250844 | PubTator, text mining | PubMed |
Vital Hepatic Lymphoma Residuum or Excessive Immune Response? Challenging Treatment Decisions in a Patient With Systemic Lupus Erythematosus and Liver-Dominant Diffuse Large B-Cell Lymphoma: Case Report. | Front Oncol | 2021 | 35117998 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9260/papers?page=36